Dawooyinka Isku darka Go'an ee Ugu Horeeyay Ayaa Loo Bilaabay Nooca 2aad ee Sonkorowga

Siideynta Xorta ah ee HAYS 3 | eTurboNews | eTN
Avatar ee Linda Hohnholz
Written by Linda Hohnholz

Glenmark Pharmaceuticals Limited waxay soo bandhigtay qiyaas cusub oo isku dhafan oo go'an (FDC) oo ah inhibitor DPP4 (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, oo leh Pioglitazone. Kani waa summada isku darka DPP4 iyo Glitazone ee keliya ee laga heli karo Hindiya ee loogu talagalay dadka waaweyn ee qaba Nooca 2 ee sonkorowga aan la xakameynin. Glenmark waxay soo saartay FDC-gan iyada oo hoos imanaysa magaca sumadda Zita Plus Pio, oo ka kooban Teneligliptin (20 mg) + Pioglitazone (15 mg), in la qaato hal mar maalintii.

Isagoo ka faalloonaya horumarka, Alok Malik, Ku-Xigeenka Kooxda & Madaxa, Qaababka Hindiya - Glenmark Pharmaceuticals, ayaa yiri, "Macaanku waa aag muhiim ah oo diiradda saaraya Glenmark; hormood u ah bixinta fursadaha daawaynta ugu dambaysay ee bukaannada macaanka ee Hindiya. Waxaan ku faraxsanahay inaan soo bandhigno sheeko-yaqaanka Zita Plus Pio, oo ah kii ugu horreeyay ee noociisa ah ee Hindiya; siinta daweyn heer caalami ah oo la awoodi karo oo la siinayo bukaannada waaweyn ee macaanka qaba."

Glenmark waa shirkaddii ugu horeysay ee Hindiya si ay u suuq geyso FDC-da cusub ee Teneligliptin + Pioglitazone, oo ay ansixisay DCGI (Maamulaha Guud ee Dawooyinka Hindiya). Isku darka qiyaasta go'an waxay faa'iido u yeelan doontaa bukaanada u baahan daawaynta Teneliglitptin iyo Pioglitazone (sida dawooyin gaar ah) si loo hagaajiyo xakamaynta glycemic yaraynta iska caabinta Insulin. 

Nooca 2 ee sonkorowga ayaa caadi ahaan la kulma arrimo ku saabsan cilladda unugyada β iyo caabbinta insulin. Glenmark's FDC ee Teneligliptin + Pioglitazone ayaa leh waxtarka uu wax kaga qabanayo labadan cudur-siyeed ee ugu muhiimsan taasoo ka dhigaysa FDC mid waxtar u leh maaraynta nooca 2 ee sonkorowga aan la xakameynin. Isku darka Teneligliptin + Pioglitazone waxay bixin doontaa hab isku dheelitiran oo Teneligliptin ay si wanaagsan u wanaajin doonto dareenka unugyada β, Pioglitazone waxay si wax ku ool ah u yaraynaysaa iska caabbinta insulin.

Wax ku biirinta Glenmark ee daaweynta sonkorowga

Sannadkii 2015, Glenmark waxa ay wax ka beddeshay suuqa sonkorowga iyada oo soo saartay DPP4 inhibitorkeeda - Teneligliptin gudaha Hindiya, oo ay ku xigto FDC ee Teneligliptin + Metformin. Glenmark waxay leedahay dhaxal xooggan oo in ka badan afartan sano oo horumar iyo hal-abuurnimo ah. Iyada oo ku sii socota markii ugu horreysay ee dhaxalka Hindiya, waxay soo saartay FDC ee Teneligliptin + Remogliflozin sanadka 2021.

Hindiya waxaa loo yaqaanaa inay tahay caasimadda adduunka ee sonkorowga. Marka loo eego Xiriirka Caalamiga ah ee Sonkorowga (IDF), faafidda cudurka macaanka ee Hindiya waa ku dhawaad ​​​​74 milyan oo qaangaar ah, kaas oo la filayo inuu kordho 125 milyan (ku dhawaad ​​​​70% koror) 2045[i]. Kuwaas, 77% bukaannada ayaa qaba cudurka macaanka oo aan la xakameynin.

War ku saabsan qoraaga

Avatar ee Linda Hohnholz

Linda Hohnholz

Tafatiraha guud ee eTurboNews ku salaysan eTN HQ.

Rukumo
Ogeysii
martida
0 Comments
Jawaabaha Gudaha ah
Eeg dhammaan faallooyinka
0
Waan jeclaan lahaa fikradahaaga, fadlan faallo ka bixi.x
()
x
La wadaag...